Margolis Seminars

Margolis Seminars in Health Policy & Management are held approximately every other Friday from 12-1:30 pm

Attendees include faculty, staff, and students from departments across Duke, as well as (by videoconference) the Margolis Center office in Washington, DC. The seminars aim to connect the Duke-wide health policy community, and to help people form, develop, and shape their health policy-related work. Most seminars cover research or policy analysis in progress, while others include presentations by faculty, staff, and visitors on significant newly-released research or legislation/regulations. If you are interested in attending or presenting at seminar, or wish to be added to the seminar email list, please email Hilary Campbell.

2018 Seminar Dates

January 5, 19
February 16
March 2, 16, 30
April 20
May 4, 18
June 1
July 6
August 3, 17
September 7, 21
October 5, 19
November 2
December 7

Past Speakers and Topics

March 30, 2018

Controlling Costs in Massachusetts
Stuart Altman (Brandeis University, The Heller School for Social Policy and Management)

New Cost Data & Brainstorm
Chad Mather (Duke Orthopaedic Surgery)

March 16, 2018
Shared decision making for critically ill infants
Monica Lemmon

Cost-Effectiveness Analysis of Financial Incentives for Smoking Cessation in NC Medicaid
Madhu Vulimiri

March 2, 2018
Policy Implications for Scaling Research Studies with Physical Therapists as Entry Level Providers
Adam Goode, Janet Bettger, and Kyle Covington

Ten Tips for Working with the Media
Ellen de Graffenreid

February 16, 2018
Diagnostic Innovation: Patent and Regulatory Considerations
Arti Rai

Value-of-Information Analysis in Health Policy: Should I Look Some More Before I Leap?
Evan Myers

January 26, 2018
Medicare Shared Savings Program: Patient Outcomes Following Ischemic Stroke
Brystana Kaufman (DCRI Fellow | PhD Candidate)

The Public Health Impact of FDA Safety Labeling Changes: Findings from a Literature Review
Liz Richardson & Colleagues (Duke-Margolis DC Office)

January 5, 2018
Tapping Margolis expertise on serious illness care inside ACOs
Robert Saunders

Overviews of recently funded projects:
Value of Hope Project (PhRMA Foundation) -- Shelby Reed
Center for Child and Family Policy Collaboration Project (Duke Endowment) -- Andrew Olsen

Open Discussion with Mark McClellan on federal health reform issues (CHIP, Medicaid, government research funding, etc.)

December 8, 2017
Joining Forces: How Advocates Can Lead Researchers Out of the Ivory Tower co-sponsored by the Duke Council on Race and Ethnicity (DCORE) and the Duke-Margolis Center for Health Policy.
Donna Biederman, Assistant Professor of Nursing, Duke University
Emily Carmody, NC Coalition to End Homelessness
Mina R. Silberberg, Associate Professor in Community and Family Medicine, Duke University

    November 10, 2017
    APMs at Duke: a view from the trenches
    George Cheely

    Impact of the Affordable Care Act on Insurance Status of Non-Elderly US Adults with Atherosclerotic Cardiovascular Disease
    Haider Warraich

    October 27, 2017
    The Duke Joint Health Program: a new care model to address costs and utilization for the care of patients with hip or knee osteoarthritis
    Chad Mather, Jonathan O’Donnell, Morven Ross, Bill Jiranek

    State Choices for CSR Non-payment
    David Anderson

    October 13, 2017
    Quality in Cancer Care: Evaluating the Commission on Cancer’s Quality Measures
    Rachel Greenup/Daniel Nussbaum/team members

    Politics of CHW Scope and Medication Management in the Community
    Bradi Granger

    September 29, 2017
    The Pharma Social Contract
    Steve Usdin, BioCentury

    Rationing by Roadblocks: Impact of prior authorization and copays on access to PCSK9 inhibitors
    Ann Marie Navar

    Recent CMMI Payment Reform Announcement
    Mark McClellan

    September 15, 2017
    Managed Care Reform and Prospects for Medicaid Expansion in North Carolina
    Andrew Olson

    Strategic Vision for Multi-State Data Collaboration: Starting with Opioids
    Aaron McKethan

    August 4, 2017
    ACA Repeal and Replace: What’s Next
    Mark McClellan, Rob Saunders

    Building a Patient Centered Home for Osteoarthritis
    Chad Mather, Jonathan O’Donnell

    Mexican Health System Data
    Ramon Torras

    Defining a Crosswalk from Health Data to Health and Policy
    Victoria Christian

    July 14, 2017
    Defensive Medicine: Evidence from Military Immunity
    Michael Frakes

    Incentivizing Healthy Behaviors in Medicaid Programs: Is there a secret sauce?
    Charlene Wong, Rob Saunders, Will Bleser, and Megan Moore

    June 16, 2017
    Brief description of the Society of Actuaries and its role in all commercial insurance planning. Overview of white paper; Attribution: Basis for All Value Based Care - attribution as the main way to show who’s responsible and accountable for performance and technical insurance risk.
    Matthew Harker

    Keeping Up with Consumers: How can mHealth apps and wearables help evaluate medical products?
    Christina Silcox, Jonathan Bryan, and Isha Sharma

    We have a decade of evidence regarding the utility of Community Health Workers in the management of chronic disease. How do we take the leap into APMs in advance of the transition from fee-for-service to capitation? What are we missing?
    Bradi Granger and Andrew Olson

    June 2, 2017
    A Multi-Methods Examination of Accountable Care Organizations: What affects ACO performance and survival?
    Will Bleser

    Daily Financial Incentives to Improve Glucose Monitoring Adherence and Glycemic Control among Adolescents and Young Adults with Type 1 Diabetes: A Randomized Controlled Trial
    Charlene Wong

    May 19, 2017
    The Costs of Healthcare Billing
    Barak Richman

    How does Medicare Reimbursement Affect Drug Prices? Question for the group: If we placed a cap on U.S. drug prices, what should it be?
    David Ridley

    May 5, 2017
    Integrated Payment and Delivery Innovations to Address US Healthcare Needs
    Krishna Udayakumar

    Supporting Biomedical and Care Delivery Policy and Innovation in Singapore and Southeast Asia
    Krishna Udayakumar

    Discussion of CPM (contralateral prophylactic mastectomy) between Patients and Surgeons
    Vinay Choksi

    April 14, 2017
    Insurance Carrier Pricing Strategies for the Subsidized Exchange Market
    Dave Anderson

    Current policy issues related to off-label communication of pharmaceuticals
    Morgan Romine

    March 31, 2017
    Measuring the Value of Hope
    Shelby Reed

    Intervention to Promote Financial Literacy Among Cancer Patients
    Yousuf Zafar

    March 17, 2017
    Challenges in Measuring Patient Data
    Heather Colvin

    Study Recruitment Challenges
    Matt Harker

    American Health Care Act Discussion
    Rob Saunders 

    February 24, 2017
    Synthesizing Evidence and Cost-Effectiveness Analyses to Inform Value-Based Frameworks
    Gillian Sanders-Schmidler

    ACA Reform Status and Next Steps – Political and Analytic
    Mark McClellan